These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 10065783

  • 1. Influence of body mass on the hypothalamic-pituitary-adrenal-axis response to naloxone in patients with polycystic ovary syndrome.
    Guido M, Ciampelli M, Fulghesu AM, Pavone V, Barini A, de Marinis L, Cento R, Caruso A, Lanzone A.
    Fertil Steril; 1999 Mar; 71(3):462-7. PubMed ID: 10065783
    [Abstract] [Full Text] [Related]

  • 2. Hypothalamic-pituitary-adrenal axis sensitivity to opioids in women with polycystic ovary syndrome.
    Ciampelli M, Guido M, Cucinelli F, Cinque B, Barini A, Lanzone A.
    Fertil Steril; 2000 Apr; 73(4):712-7. PubMed ID: 10731530
    [Abstract] [Full Text] [Related]

  • 3. Evidence of a disturbance of the hypothalamic-pituitary-adrenal axis in polycystic ovary syndrome: effect of naloxone.
    Lanzone A, Guido M, Ciampelli M, Fulghesu AM, Pavone V, Proto C, Caruso A, Mancuso S.
    Clin Endocrinol (Oxf); 1996 Jul; 45(1):73-7. PubMed ID: 8796141
    [Abstract] [Full Text] [Related]

  • 4. Somatostatin treatment reduces the exaggerated response of adrenocorticotropin hormone and cortisol to corticotropin-releasing hormone in polycystic ovary syndrome.
    Lanzone A, Fulghesu AM, Guido M, Cucinelli F, Caruso A, Mancuso S.
    Fertil Steril; 1997 Jan; 67(1):34-9. PubMed ID: 8986680
    [Abstract] [Full Text] [Related]

  • 5. Hypothalamic-pituitary-adrenal axis in abdominal obesity: effects of dexfenfluramine.
    Boushaki FZ, Rasio E, Serri O.
    Clin Endocrinol (Oxf); 1997 Apr; 46(4):461-6. PubMed ID: 9196609
    [Abstract] [Full Text] [Related]

  • 6. Interactions between the stimulated hypothalamic-pituitary-adrenal axis and leptin in humans.
    Nye EJ, Bornstein SR, Grice JE, Tauchnitz R, Hockings GI, Strakosch CR, Jackson RV, Torpy DJ.
    J Neuroendocrinol; 2000 Feb; 12(2):141-5. PubMed ID: 10718909
    [Abstract] [Full Text] [Related]

  • 7. Hyperandrogenism in women with polycystic ovary syndrome persists after menopause.
    Markopoulos MC, Rizos D, Valsamakis G, Deligeoroglou E, Grigoriou O, Chrousos GP, Creatsas G, Mastorakos G.
    J Clin Endocrinol Metab; 2011 Mar; 96(3):623-31. PubMed ID: 21177795
    [Abstract] [Full Text] [Related]

  • 8. Adrenal androgen excess in the polycystic ovary syndrome: sensitivity and responsivity of the hypothalamic-pituitary-adrenal axis.
    Azziz R, Black V, Hines GA, Fox LM, Boots LR.
    J Clin Endocrinol Metab; 1998 Jul; 83(7):2317-23. PubMed ID: 9661602
    [Abstract] [Full Text] [Related]

  • 9. Classification of polycystic ovary syndrome into three types according to response to human corticotropin-releasing hormone.
    Kondoh Y, Uemura T, Ishikawa M, Yokoi N, Hirahara F.
    Fertil Steril; 1999 Jul; 72(1):15-20. PubMed ID: 10428142
    [Abstract] [Full Text] [Related]

  • 10. Nalmefene causes greater hypothalamic-pituitary-adrenal axis activation than naloxone in normal volunteers: implications for the treatment of alcoholism.
    Schluger JH, Ho A, Borg L, Porter M, Maniar S, Gunduz M, Perret G, King A, Kreek MJ.
    Alcohol Clin Exp Res; 1998 Oct; 22(7):1430-6. PubMed ID: 9802524
    [Abstract] [Full Text] [Related]

  • 11. Effect of the opioid blockade on the feeding-induced growth hormone response to growth hormone-releasing hormone in women with polycystic ovary syndrome.
    Guido M, Romualdi D, Mancini A, Lattanzi F, Villa P, Barini A, Lanzone A, De Marinis L.
    Fertil Steril; 2002 Nov; 78(5):994-1000. PubMed ID: 12413983
    [Abstract] [Full Text] [Related]

  • 12. Naloxone-mediated activation of the hypothalamic-pituitary-adrenal axis in chronic fatigue syndrome.
    Scott LV, Burnett F, Medbak S, Dinan TG.
    Psychol Med; 1998 Mar; 28(2):285-93. PubMed ID: 9572086
    [Abstract] [Full Text] [Related]

  • 13. Response of the hypothalamic-pituitary-adrenal axis to small dose arginine-vasopressin and daily urinary free cortisol before and after alprazolam pre-treatment differs in obesity.
    Vicennati V, Ceroni L, Gagliardi L, Pagotto U, Gambineri A, Genghini S, Pasquali R.
    J Endocrinol Invest; 2004 Jun; 27(6):541-7. PubMed ID: 15717651
    [Abstract] [Full Text] [Related]

  • 14. Comment: response of the hypothalamic-pituitary-adrenocortical axis to high-protein/fat and high-carbohydrate meals in women with different obesity phenotypes.
    Vicennati V, Ceroni L, Gagliardi L, Gambineri A, Pasquali R.
    J Clin Endocrinol Metab; 2002 Aug; 87(8):3984-8. PubMed ID: 12161547
    [Abstract] [Full Text] [Related]

  • 15. Combined receptor antagonist stimulation of the hypothalamic-pituitary-adrenal axis test identifies impaired negative feedback sensitivity to cortisol in obese men.
    Mattsson C, Reynolds RM, Simonyte K, Olsson T, Walker BR.
    J Clin Endocrinol Metab; 2009 Apr; 94(4):1347-52. PubMed ID: 19141586
    [Abstract] [Full Text] [Related]

  • 16. Hypothalamo-pituitary-adrenal axis dysfunction in chronic fatigue syndrome, and the effects of low-dose hydrocortisone therapy.
    Cleare AJ, Miell J, Heap E, Sookdeo S, Young L, Malhi GS, O'Keane V.
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3545-54. PubMed ID: 11502777
    [Abstract] [Full Text] [Related]

  • 17. The influence of combined oral contraceptives containing drospirenone on hypothalamic-pituitary-adrenocortical axis activity and glucocorticoid receptor expression and function in women with polycystic ovary syndrome.
    Macut D, Božić Antić I, Nestorov J, Topalović V, Bjekić Macut J, Panidis D, Kastratović Kotlica B, Papadakis E, Matić G, Vojnović Milutinović D.
    Hormones (Athens); 2015 Aug; 14(1):109-17. PubMed ID: 25402380
    [Abstract] [Full Text] [Related]

  • 18. Hypothalamic-pituitary-adrenocortical axis hypersensitivity and glucocorticoid receptor expression and function in women with polycystic ovary syndrome.
    Milutinović DV, Macut D, Božić I, Nestorov J, Damjanović S, Matić G.
    Exp Clin Endocrinol Diabetes; 2011 Nov; 119(10):636-43. PubMed ID: 22068557
    [Abstract] [Full Text] [Related]

  • 19. Abnormalities of the hypothalamic-pituitary-adrenal axis in nondepressed women with abdominal obesity and relations with insulin resistance: evidence for a central and a peripheral alteration.
    Vicennati V, Pasquali R.
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4093-8. PubMed ID: 11095438
    [Abstract] [Full Text] [Related]

  • 20. Aspirin increases the human hypothalamic-pituitary-adrenal axis response to naloxone stimulation.
    Hockings GI, Grice JE, Crosbie GV, Walters MM, Jackson AJ, Jackson RV.
    J Clin Endocrinol Metab; 1993 Aug; 77(2):404-8. PubMed ID: 8393884
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.